Rituximab Therapy for Primary Sjögren's Syndrome
Primary Sjögren's syndrome (pSS) is a systemic autoimmune diseases of the connective tissues, characteristic of the presentation of keratoconjunctivitis sicca and xerostomia. A cardinal pathogenetic feature of SS is B-cell hyperactivity, which has invited efforts on optimal B-cell targeted ther...
Saved in:
Main Authors: | Yi Han Chen (Author), Xin Yu Wang (Author), Xin Jin (Author), Zi Yang (Author), Jianguang Xu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
B-cell depletion and primary Sjögren's syndrome: is there a role for rituximab?
by: P. Sarzi-Puttini, et al.
Published: (2011) -
Primary Sjögren's Syndrome
by: M. Šembera, et al.
Published: (2018) -
Mesenchymal Stem Cells in Primary Sjögren's Syndrome: Prospective and Challenges
by: Weiqian Chen, et al.
Published: (2018) -
Histopathological differences between primary Sjögren's syndrome and Sjögren's syndrome accompanied by scleroderma
by: Ulku Kucuk, et al.
Published: (2018) -
Therapeutic effect of modified zengye decoction on primary Sjogren's syndrome and its effect on plasma exosomal proteins
by: Yimin Zeng, et al.
Published: (2022)